Cellebrite DI (CLBT) Beginning Cash Balance (2021 - 2026)

Cellebrite DI has reported Beginning Cash Balance for 6 years, with the latest figure at $124.5 million in Q2 2026.

• On a quarterly basis, Beginning Cash Balance fell 35.06% year-over-year to $124.5 million in Q2 2026; TTM through Jun 2026 was $124.5 million, a 35.06% decrease from a year earlier, with the FY2025 full-year figure at $281.4 million, up 48.46% from the prior year.
• Beginning Cash Balance was $124.5 million for Q2 2026 at Cellebrite DI, roughly flat from $124.5 million in the prior quarter.
• The five-year high for Beginning Cash Balance was $281.4 million in Q4 2025, with the low at $87.6 million in Q1 2023.
• Average Beginning Cash Balance over 5 years is $159.4 million, with a median of $146.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Beginning Cash Balance slumped 39.96% in 2023, then jumped 116.23% in 2024.
• Over 5 years, Beginning Cash Balance stood at $146.0 million in 2022, then slipped by 6.1% to $137.1 million in 2023, then jumped by 38.27% to $189.5 million in 2024, then surged by 48.46% to $281.4 million in 2025, then sank by 55.77% to $124.5 million in 2026.
• The last three Beginning Cash Balance figures came in at $124.5 million (Q2 2026), $124.5 million (Q1 2026), and $281.4 million (Q4 2025), per Business Quant data.